Medicine and Dentistry
Pulmonary Hypertension
100%
Systemic Scleroderma
23%
Right Ventricular Function
16%
Cardiac Magnetic Resonance Imaging
15%
Scleroderma
11%
Disease
10%
Hemodynamic
9%
Polycyclic Aromatic Hydrocarbon
8%
Lung Vascular Resistance
8%
Cardiac Catheterization
7%
Angiogenesis
6%
Transplantation
6%
Combination Therapy
6%
Endostatin
5%
Ambrisentan
5%
Tadalafil
5%
Afterload
5%
Ejection Fraction
5%
Keyphrases
Pulmonary Arterial Hypertension
39%
Pulmonary Hypertension
36%
Right Ventricular Function
17%
Right Ventricular
14%
Apoptosis
12%
Caspase-3
11%
Systemic Sclerosis
10%
Tuberous Sclerosis Complex
8%
Cardiac Magnetic Resonance Imaging (cMRI)
7%
Hypertension Patients
7%
Lung
7%
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
6%
Scleroderma
5%
Xanthine Oxidase
5%
Upfront Combination Therapy
5%
Renal Tumor
5%
Tumor Cells
5%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
5%
Right Ventricle
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
44%
Hypoxia
11%
Systemic Sclerosis
11%
Disease
9%
Mouse
9%
Scleroderma
8%
Xanthine Oxidase
8%
Polycyclic Aromatic Hydrocarbon
7%
Protein Kinases
6%
Caspase 3
6%
Mitogen Activated Protein Kinase
6%
Combination Therapy
6%
Macrophage Migration Inhibition Factor
5%
Cigarette Smoke
5%
Ambrisentan
5%
Okadaic Acid
5%
Kidney Tumour
5%
Tadalafil
5%
